Suppr超能文献

捕捉帕金森病中的主观轻度认知衰退

Capturing Subjective Mild Cognitive Decline in Parkinson's Disease.

作者信息

Rosenblum Sara, Meyer Sonya, Richardson Ariella, Hassin-Baer Sharon

机构信息

Laboratory of Complex Human Activity and Participation (CHAP), Department of Occupational Therapy, Faculty of Social Welfare & Health Sciences, University of Haifa, Haifa 3498838, Israel.

Department of Occupational Therapy, Ariel University, Ariel 4077603, Israel.

出版信息

Brain Sci. 2022 Jun 5;12(6):741. doi: 10.3390/brainsci12060741.

Abstract

This study aimed to capture subjective daily functional cognitive decline among patients with Parkinson's disease. Participants (40-79 y; 78 with Parkinson's disease and 41 healthy matched controls) completed the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Parkinson's Disease Cognitive Functional Rating Scale (CFRS), Daily Living Questionnaire (DLQ), and Time Organisation and Participation Scale (TOPS) questionnaires. Patients with Parkinson's disease were divided into groups with or without suspected mild cognitive decline according to their scores on the Cognitive Functional (CF) feature, which is based on certain items of the MDS-UPDRS. Significant between-group differences were found in the DLQ and TOPS scores. Significant correlations were found among the questionnaire results, with specific DLQ and TOPS items accounting for 35% of the variance in the CF feature, which correlated with daily cognitive functional states. This study's results are relevant for detecting subtle deficits in Parkinson's disease patients suspected of mild cognitive decline, which can affect health and quality of life and relates to risk for later dementia.

摘要

本研究旨在捕捉帕金森病患者日常主观功能性认知衰退情况。参与者年龄在40 - 79岁之间(78例帕金森病患者和41例健康匹配对照),完成了统一帕金森病评定量表(MDS - UPDRS)、帕金森病认知功能评定量表(CFRS)、日常生活问卷(DLQ)以及时间组织与参与量表(TOPS)问卷。根据基于MDS - UPDRS某些项目的认知功能(CF)特征得分,将帕金森病患者分为疑似轻度认知衰退组和非疑似轻度认知衰退组。在DLQ和TOPS得分上发现了显著的组间差异。问卷结果之间存在显著相关性,特定的DLQ和TOPS项目占CF特征变异的35%,CF特征与日常认知功能状态相关。本研究结果对于检测疑似轻度认知衰退的帕金森病患者的细微缺陷具有重要意义,这些缺陷可能影响健康和生活质量,并与后期痴呆风险相关。

相似文献

1
Capturing Subjective Mild Cognitive Decline in Parkinson's Disease.
Brain Sci. 2022 Jun 5;12(6):741. doi: 10.3390/brainsci12060741.
4
Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.
J Neurol Sci. 2016 Feb 15;361:66-71. doi: 10.1016/j.jns.2015.12.018. Epub 2015 Dec 11.
6
Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.
Parkinsonism Relat Disord. 2013 Sep;19(9):812-7. doi: 10.1016/j.parkreldis.2013.05.007. Epub 2013 Jun 15.
8
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
10
Dementia and functional decline in patients with Parkinson's disease.
Dement Neuropsychol. 2008 Apr-Jun;2(2):96-101. doi: 10.1590/S1980-57642009DN20200004.

引用本文的文献

1
Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson's disease.
NPJ Digit Med. 2025 Jul 26;8(1):482. doi: 10.1038/s41746-025-01862-1.
2
Capturing subjective cognitive decline with a new combined index in low education patients with Parkinson's disease.
Front Neurol. 2024 Aug 19;15:1403105. doi: 10.3389/fneur.2024.1403105. eCollection 2024.
3
Neurocognitive Impairment and Social Cognition in Parkinson's Disease Patients.
Neurol Int. 2024 Apr 16;16(2):432-449. doi: 10.3390/neurolint16020032.
4
Different associated factors of subjective cognitive complaints in patients with early and advanced Parkinson's disease.
Front Aging Neurosci. 2023 Dec 1;15:1257799. doi: 10.3389/fnagi.2023.1257799. eCollection 2023.
5
Cognitive Complaints and Their Impact on Daily Life in Patients with Degenerative Cerebellar Disorders.
Cerebellum. 2024 Jun;23(3):1042-1052. doi: 10.1007/s12311-023-01607-4. Epub 2023 Oct 2.
6
Subjective cognitive decline in patients with Parkinson's disease: an updated review.
Front Aging Neurosci. 2023 May 26;15:1117068. doi: 10.3389/fnagi.2023.1117068. eCollection 2023.

本文引用的文献

2
"Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
Neurol Sci. 2021 Dec;42(12):4927-4936. doi: 10.1007/s10072-021-05601-8. Epub 2021 Sep 17.
3
The Montreal Cognitive Assessment: Is It Suitable for Identifying Mild Cognitive Impairment in Parkinson's Disease?
Mov Disord Clin Pract. 2020 Jun 25;7(6):648-655. doi: 10.1002/mdc3.12969. eCollection 2020 Aug.
4
Update on the Management of Parkinson's Disease for General Neurologists.
Parkinsons Dis. 2020 Mar 26;2020:9131474. doi: 10.1155/2020/9131474. eCollection 2020.
6
Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge.
Front Aging Neurosci. 2019 Nov 8;11:303. doi: 10.3389/fnagi.2019.00303. eCollection 2019.
7
Mild cognitive impairment in Parkinson's disease.
J Neural Transm (Vienna). 2019 Jul;126(7):897-904. doi: 10.1007/s00702-019-02003-1. Epub 2019 Apr 8.
8
Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.
Mov Disord. 2018 Nov;33(11):1760-1768. doi: 10.1002/mds.27487. Epub 2018 Oct 10.
9
Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study.
Parkinsons Dis. 2018 Apr 8;2018:1362053. doi: 10.1155/2018/1362053. eCollection 2018.
10
Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.
Mov Disord. 2018 Apr;33(4):503-510. doi: 10.1002/mds.27323. Epub 2018 Feb 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验